Source: Annual Congress 2002 - Treatment and outcome of acute respiratory failure in chronic disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Babores, P. M. A. Calverley, L. Davies (Liverpool, United Kingdom). Inappropriate oxygen therapy and its consequences in chronic obstructive pulmonary disease (COPD). Eur Respir J 2002; 20: Suppl. 38, 601

Member's Comments

No comment yet.

Related content which might interest you: Oxygen therapy in chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=302 Year: 2006 Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 427s Year: 2003 Use of spirometry screening for patients with chronic obstructive pulmonary disease (COPD) requiring oxygen therapy Source: Eur Respir J 2006; 28: Suppl. 50, 838s Year: 2006 Should all chronic obstructive pulmonary disease (COPD) patients with cardiac co-morbidities have ambulatory oxygen assessment? Source: Annual Congress 2008 - Exercise: system responses Year: 2008 Therapeutic approaches in the chronic obstructive (COPD) pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 472s Year: 2002 Influence of bronchodilators on pulmonary hypertension (PH) in patients with moderate and severe chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 310s Year: 2005 Drugs (including oxygen) in severe COPD Source: Eur Respir J 2008; 31: 1114-1124 Year: 2008 Respiratory failure in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 26S Year: 2003 Optimal assessment and management of chronic obstructive pulmonary disease (COPD) Source: Guideline 1995 Year: 1995 Acute effects of sildenafil in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008 Effect of hospitalization on exercise capacity in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2012 - Methodology in epidemiologic research Year: 2012 Pathogenic therapy of patients with chronic obstructive pulmonary diseases (COPD) Source: Annual Congress 2007 - New insights into the treatment of COPD Year: 2007 Predictors of arrhythmias in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) and COPD concomitant with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 521s Year: 2004 Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Correlates of osteoporosis in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Reversibility of airflow limitation in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 587s Year: 2004 Ventilatory and perfusion defects in chronic obstructive pulmonary disease (COPD) and response to bronchodilators Source: Annual Congress 2007 - Imaging of pulmonary vascularisation and illustrated overview of lung pathology Year: 2007 The effects of uncontrolled oxygen therapy in the ambulance on outcome of patients admitted with exacerbation of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2004 - Acute exacerbations and drug therapy in COPD Year: 2004 Potential biomarkers in patients with chronic obstructive pulmonary disease (COPD) Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020